Peer review reports
From: Difference in drug cost between private and public drug plans in Quebec, Canada
Original Submission | ||
---|---|---|
2 Jun 2021 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
14 Jul 2021 | Reviewed | Reviewer Report |
23 Jul 2021 | Reviewed | Reviewer Report |
29 Sep 2021 | Author responded | Author comments - Lucie Blais |
Resubmission - Version 4 | ||
29 Sep 2021 | Submitted | Manuscript version 4 |
30 Sep 2021 | Author responded | Author comments - Lucie Blais |
Resubmission - Version 5 | ||
30 Sep 2021 | Submitted | Manuscript version 5 |
7 Oct 2021 | Author responded | Author comments - Lucie Blais |
Resubmission - Version 6 | ||
7 Oct 2021 | Submitted | Manuscript version 6 |
30 Oct 2021 | Author responded | Author comments - Lucie Blais |
Resubmission - Version 7 | ||
30 Oct 2021 | Submitted | Manuscript version 7 |
2 Nov 2021 | Reviewed | Reviewer Report |
13 Nov 2021 | Reviewed | Reviewer Report |
20 Jan 2022 | Author responded | Author comments - Lucie Blais |
Resubmission - Version 8 | ||
20 Jan 2022 | Submitted | Manuscript version 8 |
Publishing | ||
3 Feb 2022 | Editorially accepted | |
14 Feb 2022 | Article published | 10.1186/s12913-022-07611-4 |